Status:
COMPLETED
Effects of 24-week Computerized Cognitive Training in Patients With MCI and AD
Lead Sponsor:
Chongqing Medical University
Conditions:
Mild Cognitive Impairment
Alzheimer Disease
Eligibility:
All Genders
55-90 years
Phase:
NA
Brief Summary
This study aims to testify multi-domain effects of computerized cognitive training in patients with mild cognitive impairment and mild Alzheimer's disease through multi-dimensional evaluation.
Detailed Description
This study aimed to elucidate the neural process enhancement and remodulation in gut microbes resulting from older adults with MCI and mild AD in a randomized controlled trial of a 24-week computerize...
Eligibility Criteria
Inclusion
- between 55 and 90 years of age;
- a Clinical Dementia Rating (CDR) score of 0.5 or 1;
- at least three months of stable doses if receiving antidementia medication or mood-stabilizing medication for mild AD participants;
- primary school education and above;
- accompanied by a consistent caregiver (at least 5 days/week);
- informed consent.
Exclusion
- factors that might preclude completion of assessments;
- severe psychiatric illness and the use of antidepressants;
- any condition that would preclude completion of training and follow-up tests;
- other disorders that would affect cognition.
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 19 2022
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06094452
Start Date
October 21 2020
End Date
August 19 2022
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016